Tangible pathologies in functional dyspepsia.

Atopy Autoimmune Dysbiosis Dysmotility Eosinophil Functional dyspepsia Genetics Pathology Therapy

Journal

Best practice & research. Clinical gastroenterology
ISSN: 1532-1916
Titre abrégé: Best Pract Res Clin Gastroenterol
Pays: Netherlands
ID NLM: 101120605

Informations de publication

Date de publication:
Historique:
received: 20 02 2019
revised: 05 08 2019
accepted: 12 08 2019
entrez: 10 10 2019
pubmed: 9 10 2019
medline: 4 12 2019
Statut: ppublish

Résumé

Functional dyspepsia (FD) is a common, costly and complex disease, currently defined by symptoms, directed by the Rome consensus on functional bowel disorders, which has evolved over the past two decades. Symptoms include abdominal pain, are often meal related and there are two major subtypes, postprandial distress syndrome and epigastric pain syndrome, not attributed to pathology. Increasingly it is recognised that tangible pathologies occur in FD, for example Helicobacter pylori and other pathophysiological changes, most notably duodenal pathology, namely duodenal eosinophilia, permeability alterations, structural neuronal changes and microbial duodenal dysbiosis. This has led to the idea that FD is a true disease entity and triggers of this condition based on epidemiology studies point towards allergy, immune disorders and infection. Anxiety and depression may precede or follow FD, (brain-gut/gut-brain disorders). Currently most therapies for FD are inadequate but underlying pathology may lead to targeted treatment success as an attainable goal.

Identifiants

pubmed: 31594648
pii: S1521-6918(19)30053-8
doi: 10.1016/j.bpg.2019.101650
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101650

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Marjorie M Walker (MM)

Faculty of Health and Medicine, University of Newcastle, HMRI Building, Kookaburra Circuit, New Lambton Heights, 2305 NSW, Australia; School of Medicine & Public Health, University of Newcastle Callaghan 2308, NSW Australia; Australian Gastrointestinal Research Alliance, University of Newcastle, NSW, Australia. Electronic address: marjorie.walker@newcastle.edu.au.

Michael D Potter (MD)

Faculty of Health and Medicine, University of Newcastle, HMRI Building, Kookaburra Circuit, New Lambton Heights, 2305 NSW, Australia; School of Medicine & Public Health, University of Newcastle Callaghan 2308, NSW Australia; Australian Gastrointestinal Research Alliance, University of Newcastle, NSW, Australia. Electronic address: michael.potter@newcastle.edu.au.

Nicholas J Talley (NJ)

Faculty of Health and Medicine, University of Newcastle, HMRI Building, Kookaburra Circuit, New Lambton Heights, 2305 NSW, Australia; Australian Gastrointestinal Research Alliance, University of Newcastle, NSW, Australia. Electronic address: nicholas.talley@newcastle.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH